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Abstract
Background: Brisken et al (2000) showed that Wnt4 null mammary glands were deficient in early
lobuloalveolar mammary outgrowth during pregnancy, and implicated Wnt4 as an effector for the
progesterone-induced mammary growth program. Though ectopic Wnt1 signaling is known to be
mitogenic and oncogenic, no endogenously expressed Wnt ligands have ever been directly
implicated in mammary growth and morphogenesis. Therefore, we generated conditional
transgenic mice to test whether Wnt4 can stimulate mammary epithelial cell growth.
Results: We found that despite pregnancy-associated expression levels of Wnt4, mammary glands
did not display the side-branching typical of early pregnancy. Control experiments designed to test
the Wnt4 construct in zebrafish reproduced other studies that demonstrated Wnt4-specific
phenotypes distinct from Wnt1-induced phenotypes. Indeed, using qPCR-based array analyses, we
found that a specific transcriptional target of Wnt4, namely Wnt16, was induced in Wnt4-
expressing transgenic glands, to levels equivalent to that of early pregnant glands.
Conclusion: Taken together, we propose that Wnt4 is necessary, but not sufficient, to induce
side-branch development.
Background
Wnt signaling has been implicated in mammary gland
development [1], particularly during the specification of
mammary placodes from ectoderm (revealed by LEF1-
deficient, and K5-dkk1 transgenic glands) [2-4]. Our data
have shown that LRP-5, one of two canonical Wnt signal-
ing receptors, is required for ductal stem cell maintenance
[5]. Since several Wnt family genes are differentially
expressed in the virgin, pregnant, and lactating mammary
gland, some of them regulated by ovarian hormones, it
would not be surprising if these Wnt proteins have other,
as yet unidentified functions [6,7].
During pregnancy, mammary glands undergo substan-
tial changes induced by steroid and peptide hormones.
Progesterone signaling is predominantly responsible
for the growth and differentiation of the lobuloalveolar
lineage that is characteristic of early pregnancy [8].
Brisken et al (2000) concluded that Wnt4 expression
was important to side-branching and lobuloalveolar
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development during pregnancy, and was regulated by
progesterone/PR signaling. Thus, Wnt4 null epithelium
failed to form side-branches and lobuloalveoli in trans-
planted mammary fat pads during early pregnancy (12
days of pregnancy). Early developmental defects were
overcome in late stage of pregnancy [9]. In addition,
Wnt4 expression was induced in vitro in cultured mam-
mary epithelial cells by estrogen and progesterone, and
also in vivo in a progesterone-dependent manner dur-
ing the estrus cycle [9,10]. Thus Wnt4 is considered a
downstream mediator of progesterone/progesterone
receptor (PR)-induced signaling.
Wnt4 is key to several developmental processes. Wnt4
null mice have no kidneys, due to early failure of the
nephric mesenchymal-epithelial transition [11]. Wnt4 is
also key to establishing gonadal identity in females [12].
Decidualization (uterine stromal differentiation) is
induced by progesterone/BMP2, and requires Wnt4 [13].
It is active during motorneuron specification (together
with Wnt5a and-b) [14].
The molecular mechanism by which Wnt4 induces prolif-
eration and morphogenesis of mammary epithelial cells
has not been investigated. Therefore, for the present study,
we developed bi-transgenic mice that express Wnt4 in
mammary epithelial cells in response to tetracycline. By
mating tet-operator driven Wnt4 transgenic mice with
mice expressing reverse tetracycline trans-activator (rtTA)
under the control of the mouse mammary tumor virus
(MMTV)-LTR promoter, we were able to induce expres-
sion of transgene in mammary glands by doxycycline
administration. Unexpectedly (perhaps), ectopic Wnt4
expression did not induce hyper side-branching and lob-
uloalveolar development in virgin mammary glands. This
was despite clear evidence that Wnt16, a Wnt4 transacti-
vation target, was induced in response to tetracycline.
Thus, we propose that Wnt4 is required but not sufficient
for early lobuloalveolar side-branch development.
Results
Construction of tetracycline-inducible Wnt4 transgene 
cassette and generation of doxycycline-inducible Wnt4 
transgenic mice
To construct a doxycycline-inducible Wnt4 transgene cas-
sette (TMILA-Wnt4), mouse Wnt4 cDNA was subcloned
downstream of tet operator sequences (Fig. 1A), and a
minimal CMV promoter into the first cistron of a bicis-
tronic construct. Translation of a luciferase reporter gene
via an internal ribosome entry site (IRES) can be used as a
surrogate marker for transgene expression [15]. To test
whether Wnt4 and luciferase expression was regulated by
doxycycline, the TMILA-Wnt4 plasmid was transfected
into rtTA-expressing 293T (rtTA-293T) cells, and lysates
tested for luciferase activity and Wnt4 protein level (Fig.
1B). This construct showed very low basal levels of both,
that were highly induced by the administration of doxycy-
cline (1 μg/ml).
Two independent founder transgenic lines were made by
pronuclear injection of the doxycycline-inducible Wnt4
expression cassette (tet-Wnt4-IRES-luciferase) that stably
transmitted the transgene to the next generation (tet-
Wnt4A and tet-Wnt4B line). Southern blot analysis
showed that both lines have >20 copies of transgene (Fig.
1C and tet-Wnt4B data not shown).
(A) Diagram of the tetracyline-inducible Wnt4 transgene cas- sette Figure 1
(A) Diagram of the tetracyline-inducible Wnt4 trans-
gene cassette. (more details are given in the results sec-
tion) (B) Expression of Wnt4 and the luciferase reporter is 
regulated by doxycycline. 293T cells stably expressing rtTA 
were transfected with either TMILA-Wnt4 vector or paren-
tal TMILA vector. Transfected cells were incubated for 24 
hrs with or without doxycycline (1 μg/ml), and cell lysates 
were prepared to measure luciferase activity. Expression of 
Wnt4 protein was assessed through Western blot analysis 
using a mouse Wnt4-specific antibody. (C) Southern blot 
analysis of tet-Wnt4 transgenic mice. Genomic DNA from a 
non-transgenic mouse was used as a negative control and 
spiked with TMILA-Wnt4 vector fragment to determine the 
approximate copy number of the integrated transgene 
(probes and digestion as described in Methods).BMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
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Wnt4 expression is specifically induced in tet-Wnt4/
MMTV-rtTA mammary glands by doxycycline-
administration
In order to express Wnt4 specifically in mammary gland,
tet-Wnt4A and B male mice were mated with MMTV-rtTA
female mice [16]. Virgin 3~5 month old bitransgenic (tet-
Wnt4/MMTV-rtTA) female mice and non- or single-trans-
genic female littermates were administered doxycyline-
water (2 mg/ml) for one month, and luciferase activity in
mammary tissue lysates was measured (Fig. 2A). Luci-
ferase reporter gene expression was induced in tet-Wnt4A/
MMTV-rtTA or tet-Wnt4B/MMTV-rtTA mammary glands,
but not in non-transgenic, tet-Wnt4A, tet-Wnt4B, or
MMTV-rtTA mammary glands.
To measure Wnt4 expression directly in doxycyline-
treated mammary glands, we measured Wnt4 mRNA level
by real time quantitative PCR (qPCR, Fig. 2B), and com-
pared it with normal endogenous expression levels. Con-
sistent with previous reports [6,7,10], Wnt4 mRNA was
detected in juvenile and adult virgin mammary glands,
and the expression level reached a peak during early preg-
nancy (5.5~10.5 days postcoitus (d.p.)) declining (rela-
tively) during mid and late pregnancy. In both
doxycycline-administered tet-Wnt4A/MMTV-rtTA and tet-
Wnt4B/MMTV-rtTA mammary glands, Wnt4 mRNA level
was higher than early pregnant mammary glands. Wnt4
mRNA was induced to early pregnant levels in mice in
estrus (see samples marked with *), consistent with a pre-
vious report of Wnt4 mRNA induction after hormonal
exposure [10].
In order to assess induction of Wnt4 protein expression,
primary mammary epithelial cells were prepared from tet-
Wnt4A/MMTV-rtTA female mice or non-transgenic female
littermates and cultured in the presence or absence of dox-
ycycline. Wnt4 protein was only detected in doxycycline-
treated bitransgenic mammary epithelial cells (Fig. 2C).
Taken together, these data show that the expression of this
Wnt4 transgene is effectively induced by doxycyline.
Ectopic Wnt4 expression is not sufficient to induce hyper 
side-branching
To assess whether ectopic Wnt4 expression induced side
branching and lobuloalveolar growth, we examined
whole mount preparations of doxycyline-administered
mammary glands (Fig. 3). Surprisingly, neither tet-
Wnt4A/MMTV-rtTA nor tet-Wnt4B/MMTV-rtTA mam-
mary glands were significantly different from controls.
Control glands that displayed relatively more side-
branches and lobuloalveolar development (for instance,
the MMTV-rtTA mammary gland shown in Fig. 3) were
subsequently shown to have estrus-associated levels of
Wnt 4 mRNA.
Shorter or longer periods of doxycycline administration
(6 days and 3 months, respectively), or constant adminis-
tration from embryonic stages in utero or from 3 weeks old
to 3 months old also did not induce side-branch develop-
ment in bitransgenic mammary glands (data not shown).
There were no overt changes in early morphogenesis dur-
ing pregnancy, or during the first 5 days of pseudo-preg-
nancy (after mating with a vasectomized male; data not
shown). In line with their normal virgin morphology, the
mitotic indices of these bitransgenic glands were also nor-
mal (measured using Ki67 immunohistochemistry, or
BrDU incorporation; data not shown). We conclude that
ectopic Wnt4 expression is not sufficient to induce hyper
side-branching.
Wnt4 does not induce canonical Wnt signaling reporter 
gene expression in mammary epithelial and fibroblast cells 
in vitro
Recent studies suggest that the receptor species available
determine the Wnt signaling responses, rather than any
particular Wnt ligand [17,18]. Thus, Wnt ligands can
induce so-called "canonical" Wnt signaling by forming a
tertiary complex with Frizzled and LRP-5/6, while non-
canonical Wnt signaling pathways are mediated through
Frizzled alone or atypical receptor tyrosine kinases such as
Ryk and Ror [19].
To evaluate whether mammary epithelial cells in culture
could respond to Wnt4 with the activation of canonical
Wnt signaling, we measured Wnt transactivation using a
TCF-β catenin reporter assay. Primary mammary epithe-
lial cells (prepared from adult virgin mammary glands)
were transfected with Wnt ligand expression plasmids
together with the superTOP-Flash reporter plasmid
(encoding a luciferase gene downstream from eight TCF/
LEF binding sites). Wnt1, a commonly used inducer of
canonical Wnt signaling in mammary gland, was used as
a positive control. Although ectopic Wnt1 expression
induced reporter gene expression in mammary epithelial
cells, Wnt4 did not (Fig. 4A). The specificity of this
reporter gene assay was confirmed using a scrambled
superFOP-flash reporter plasmid (data not shown).
Though it is known that the effects of Wnt4 are epithelial
cell-autonomous (Brisken et al, 2000), the responder/
effector cells do not necessarily have to be epithelial.
Therefore, we tested the canonical response of mammary
fibroblast cells (Fig. 4B). Again, we showed that reporter
gene expression was easily induced by Wnt1 in a dose
dependent manner, but not by Wnt4. Therefore, we con-
clude that Wnt4 is not a canonical effector in either cell
context.
Wnt4 is biologically active
The lack of functional activity associated with Wnt4 in
these  in vivo and  in vitro analyses led us to examine
whether the Wnt4 expression vector was generating bio-
logically active protein. Zebrafish embryos have long been
used to study the role of various Wnt ligands during devel-BMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
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Characterization of doxycycline-inducible Wnt4 transgenic mice Figure 2
Characterization of doxycycline-inducible Wnt4 transgenic mice. (A) Luciferase reporter gene expression in tet-
Wnt4/MMTV-rtTA transgenic mammary glands. To express Wnt4 specifically in mammary glands, tet-Wnt4A and B mice were 
mated with transgenic mice that express rtTA under the control of MMTV-LTR promoter (MMTV-rtTA). The subsequent vir-
gin female littermates (3 months old) were administered doxycycline containing water (2 mg/ml) for 1 month. Mammary gland 
lysates were prepared, and the luciferase activity of 10 μg of total protein lysate was measured. N.T, non-transgenic; rtTA, 
MMTV-rtTA; W4A, tet-Wnt4A strain; W4B, independent strain tet-Wnt4B; bitransgenics are shown as W4A or B/rtTA. (B) 
Induction of Wnt4 mRNA expression in mammary glands in doxycycline-administered mice. Wnt4 mRNA level was quantified 
by real time quantitative PCR (see methods) using total RNAs from mammary glands of mice administered doxycycline for 1 
month. The fold induction is indicated with respect to control glands (from 7 week old mice). For mRNA preparations from 
non, single and bi-transgenic glands, plus designations indicate the presence of the transgene, and the order is shown as follows, 
Wnt4A/rtTA. Data marked with an asterix were samples from mice in estrus. (C) Induction of Wnt4 protein expression in 
doxycycline-treated bitransgenic mammary epithelial cells. Mammary epithelial cells were prepared from non-transgenic (-/-) 
and bitransgenic (+/+) glands and cultured for 2 days. Cells were treated with doxycycline (1 μg/ml) for another 24 hrs and 
lysates were prepared for Western blot analysis. Lysates from expression vector-transfected 293T cells were used as positive 
controls.BMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
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opment, and the expression pattern and functionality of
Wnt ligands is remarkably highly conserved between
mammals and zebrafish. Ectopic misexpression of
zebrafish Wnt4 (zWnt4; zebrafish homolog of Wnt4) dur-
ing embryogenesis has been characterized. At 26 hours,
zWnt4 mRNA-injected embryos display phenotypes (such
as cyclopia, notochord defects, misfolding or laterally dis-
placed hindbrain, and shortened trunk and tail) that arise
from an inhibition of convergence and extension move-
ment [20].
Taking advantage of this, we injected mouse Wnt4
(mWnt4) mRNA (transcribed in vitro) into fertilized
zebrafish embryos (1~4 cell stage) and examined the gain
of function phenotypes after 24~26 hours. As predicted by
the fact that mWnt4 and zWnt4 share over 80% identity
in amino acid sequences, ectopic misexpression of
mWnt4 displayed similar gain of function phenotypes to
those previously reported zWnt4-induced phenotypes,
including cyclopia, shortened tail and trunk, and abnor-
malities in brain (Fig. 5), thought to be the result of
abnormal cell movement. Furthermore, phenotypes
induced by mWnt4 were different from mWnt1. Although
ectopic misexpression of mWnt1 also displayed develop-
mental abnormalities in brain and shortened trunk and
tail, mWnt1 induced unique dorsalization phenotypes
such as "tail-up" and "bustled" [20]. We classified the gain
of function phenotypes into 4 groups (severe, strong, mild
and none), and quantified the phenotypes induced by dif-
ferent mRNA injection doses (Fig. 5). The quantification
showed that both Wnt4 and Wnt1 induced the gain of
function phenotypes in a dose dependent manner. Thus,
we confirm that mouse Wnt4 is a biologically active pro-
tein that generates distinct phenotypes from Wnt1 (per-
haps because of cell type-specific expression of Frizzled
(or other) receptors).
Wnt16 expression is induced by Wnt4 signaling
Our data show that although biologically active Wnt4
proteins are expressed in bitransgenic mammary glands,
there is no significant development of lobuloalveoli. On
the other hand, we confirmed that endogenous Wnt4
expression, associated with increased progesterone during
the estrus cycle, correlates with transient side-branching
development [10].
We presume that progesterone-regulated genes may
include both a ligand and receptor pair. To test whether a
cognate receptor (including the Frizzled (Fzd) proteins)
was missing in virgin transgenic mice compared to preg-
nant glands, we assessed the expression levels of Fzd fam-
ily genes using Wnt signaling-specific qPCR-based array
(Superarray) analyses. The Wnt signaling specific array has
96 primer sets that include most Wnt signaling compo-
nents and some housekeeping controls. We compared
gene expression in early pregnant glands with that of
transgenic doxycycline-administered tet-Wnt4/MMTV-
rtTA glands and control virgin glands (Additional Files 1,
2, 3 &4). Only a few genes are significantly up- or down-
regulated in early pregnant (5.5 d.p) glands or bitrans-
genic glands compared with virgin glands (Fig. 6A; sum-
marized in Additional File 4). Prominent amongst these
was Wnt4 (our positive control). Furthermore, contrary to
our hypothesis, although one Fzd species, Fzd9, increased
in pregnant glands, it increased more in Wnt4:rtTA trans-
genic glands, and there were no other significant and
reproducible changes in other Fzd family genes (Fig. 6A
and Additional Files 1, 2, 3 &4).
However, this analysis showed that the Wnt4 target gene,
Wnt16 (described for endometrium) [21] was induced by
13-fold and 55-fold in pregnant and transgenic glands
respectively (Fig. 6A; Additional File 4). We conclude that
there is a Wnt4-binding receptor that signals a response in
virgin gland.
In order to determine whether Wnt16 was a direct target
of Wnt4 signaling in mammary epithelial cells, HC11
cells were either transduced with recombinant retrovi-
ruses encoding Wnt signaling agonists, or they were
treated with conditioned medium from control (L cell) or
Wnt3a- L cells, and total RNAs were prepared for qPCR
analyses. Interestingly, Wnt16 expression was induced by
canonical Wnt signaling effectors (Wnt1HA, ΔNβ-catenin
(a constitutively active form of β-catenin), and Wnt3a)
but not directly by Wnt4 (Fig. 6B). We tested whether co-
addition of progesterone with Wnt4 would induce Wnt16
in HC11 cells, but it did not (data not shown). Notice that
axin2, a robust Wnt signaling reporter [22], was not signif-
icantly induced in either the Wnt4:rtTA or pregnant
glands (a result also shown by others). We cannot con-
clude whether Wnt16 is a canonical or non-canonical sig-
naling target in mammary epithelial cells in vivo.
Ectopic Wnt4 expression is not sufficient to induce hyper  side-branching Figure 3
Ectopic Wnt4 expression is not sufficient to induce 
hyper side-branching. To assess side-branching develop-
ment, inguinal #4 mammary glands were dissected out from 
the above doxycyline-treated female mice (treated with dox-
ycycline for 1 month at 3 months of age) and stained with 
Carmine solution. Scale bar = 1 mm.BMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
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Discussion
In order to study the published growth-associated activity
of Wnt4 in vivo during mammary gland development, we
generated bitransgenic mice that express Wnt4 in mam-
mary glands in a doxycyline-inducible manner. Perhaps
surprisingly, we show that despite high levels of biologi-
cally active Wnt4 in these transgenic mammary glands,
there is no induction of lobuloalveoar side branching. We
propose that Wnt4 may be necessary but not sufficient for
morphogenesis.
Wnt4 is not sufficient for lobuloalveolar development
A role for Wnt4 in lobuloalveolar development was first
proposed by Bradbury et al. [23]. This study used recom-
binant retroviruses encoding Wnt4 under the control of β-
actin promoter, to express Wnt4 ectopically in mammary
epithelial cells in culture. When transplanted in vivo into
fat pads, the transduced mammary epithelial cells devel-
oped highly branched ducts. However, only 18% of the
reconstituted glands displayed the "pregnant-like" pheno-
type, while 55% of the reconstituted glands had normal
virgin mammary gland structures. The authors proposed
that this might be the result of a low infection efficiency
or low dose of Wnt4 protein. It could be that retroviral
transduction favors fibroblasts and endothelial cells, and
that these cells modify the colonization pattern of mam-
mary epithelial cells, without having a robust effect.
Alternatively, it is possible that Wnt4 may induce ductal
side-branching only in the presence of the correct endo-
crine environment. Thus, there is evidence that progester-
one induces Wnt4 expression [10,24]. The hormone-
induced program includes many different subprograms,
and we propose that a cooperating factor is required for
Wnt4-induced development. A good candidate as this
cooperating factor is the b-HLH protein, Id4, one of the
main factors induced in vivo by progesterone-exposure of
PR-expressing luminal cells [25]. Loss of function of Id4
induces hypomorphic side-branching (Yi Li, personal
communication), and gain of function induces hyperpla-
sia (but not normal side-branching; John Lydon, personal
communication). The requirement of (an)other proges-
terone-induced factor in addition to Wnt4 during lobu-
loalveolar development is shown in summary in Fig. 7.
Another formal possibility to explain a lack of physiolog-
ical response is that the relatively higher levels of Wnt4
(mRNA) we observe in transgenic glands (1.5× early preg-
nancy levels) is too high, or that the Wnt4 protein is una-
vailable to the responder cells (expressed predominantly
in MMTV-positive luminal cells).s
To study the effect of loss of Wnt4 function, Brisken et al.
transplanted mammary rudimentary epithelium isolated
from Wnt4 null pups on the cleared fat pads (to rescue a
mutations that is perinatal lethal because it causes kidney
failure [26]. The Wnt4 null epithelium formed normal
Wnt4 does not induce canonical Wnt signaling in mammary  epithelial or fibroblast cells in vitro Figure 4
Wnt4 does not induce canonical Wnt signaling in 
mammary epithelial or fibroblast cells in vitro. (A) 
Wnt reporter assay of primary mammary epithelial cells. Pri-
mary mammary epithelial cells were transfected with super-
TOP-flash reporter gene, a Renilla luciferase gene (a 
transfection control), and various amounts of Wnt4 expres-
sion vector (0.05~2.0 μg). Luciferase activity was measured 
48 hrs after transfection, and results corrected for transfec-
tion efficiency (dividing by Renilla luciferase activity). Fold 
induction was calculated with respect to the negative control 
(LacZ-transfected cells). A Wnt1 expression vector was used 
as a positive control. (B) Wnt reporter assay of immortalized 
mammary fibroblast cells. Mammary fibroblast cells were 
prepared from FVB-Cdkn2a-/- (Ink4a/Afr null) female mice as 
described in Materials and Methods, and superTOP-flash 
reporter assays were performed as above. Error bars = 
standard deviation of triplicate samples.BMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
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ductal structures in reconstituted virgin mammary glands,
but the ductal side-branching was disrupted, specifically
during early pregnancy [9], suggesting the essential func-
tion of Wnt4 in early lobuloalveolar development. Taken
together, we propose that Wnt4 is required, but not suffi-
cient for lobuloalveolar development during early preg-
nancy.
Wnt4-induced signaling; Canonical or non-canonical?
Wnt4 has been classified as a non-canonical ligand. Thus,
unlike canonical Wnt ligands such as Wnt1 and Wnt3a,
Wnt4 was not able to transform C57 MG cells (an immor-
talized mouse mammary epithelial cell line of uncertain
origin) in vitro [27], or stabilize endogenous β-catenin
[28]. Consistent with those observations, we have shown
that Wnt4 had no effect on superTOP-flash reporter gene
expression in primary mammary epithelial cells and
mammary fibroblast cells (Fig. 4). Moreover, injection of
mouse Wnt4 to zebrafish embryos induced similar phe-
notypes to zWnt4, classified in the same functional group
as Wnt5a, a prototype agonist of non-canonical Wnt sign-
aling [20,29]. However, recent studies have shown that
when provided with correct species of Frizzled and suffi-
cient LRP protein, Wnt5a can act as a canonical agonist
[17,18]. Indeed, Wnt4 activates canonical responses in
MDCK kidney cells, and binds Fzd6, though this receptor
is unlikely to be signaling receptor [30]. Receptor context
is therefore key to the functional readout.
Often, Wnt4-dependent physiologies involve more than
one cell type. For example, Wnt4 is required for tubulo-
genesis during kidney development (perhaps a similar
epithelial process to ductal side-branch formation), and is
induced in mesenchymal cells by an epithelial cell-
derived signal [31]. Wnt4 expression induced the canoni-
cal reporter gene (TOP-gal) in mesenchymal cells [11],
and ectopic β-catenin expression was sufficient to replace
Wnt4-mediated signaling [32]. In a renal injury model,
Wnt4 was able to stabilize endogenous β-catenin and
induce reporter gene expression in certain myofibroblast
cell lines [33,34]. Furthermore, Wnt4 activated canonical
signaling in MDCK (Mardin-Darby Canine Kidney) cells
[30]. However, other data suggests that Wnt4 inhibited
canonical signaling by redirecting the subcellular localiza-
tion of β catenin [35], or that it is key to hematopoiesis
through a β catenin-independent activity [36]. These data
show that although Wnt4 can function as a canonical sig-
naling agonist in complex cell systems, it has other activi-
ties. Interestingly, expression of Wnt1 (a prototype
agonist of canonical Wnt signaling) in mammary ductal
epithelial cells through either MMTV-LTR promoter or
recombinant retrovirus also causes hyper side-branching
that cannot be recapitulated by expression of the down-
stream intracellular transactivator, β-catenin [23,37,38].
These observations support the idea that canonical signal-
ing activation by soluble Wnt ligands in nearby mesen-
Ectopic mouse Wnt4 expression induces a non-canonical Wnt phenotype during zebrafish development Figure 5
Ectopic mouse Wnt4 expression induces a non-canonical Wnt phenotype during zebrafish development. (A) 
Gain of function phenotypes induced by mouse Wnt4 in zebrafish embryo. Various doses of mouse Wnt4 or Wnt1 mRNA was 
injected to fertilized zebrafish eggs, and the phenotype was assessed 24 hrs after injection. (β-galactosidase (lacZ) mRNA was 
used as a negative control.) The phenotypes were classified into 3 groups (severe, strong and mild) based on the complexity of 
phenotype. (B) Wnt4 induces gain of function phenotypes in a dose dependent manner. On the y-axis, % total embryos are 
shown with each (color-coded) phenotype (severe to mild, shown in A), after injection with the indicated dose of control, 
Wnt1 or Wnt4 constructs.BMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
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chymal cells through a paracrine mechanism is necessary
for ductal side-branching morphogenesis [1].
Using qPCR-based array analyses, we found that Wnt16
expression is induced by Wnt4 in vivo (Fig. 6A). Further-
more, a recent study showed that expression of both Wnt4
and Wnt16 is regulated by PR and FOXO1 (forkhead tran-
scription factor 1) during differentiation of endometrial
stromal cells into decidual cells [21]. Thus, knockdown of
FOXO1 using small interfering RNAs down-regulates
Wnt4 and Wnt16 expression, and knockdown of PR dis-
rupts the regulation of Wnt4 by FOXO1 in human
endometrial stromal cells. These data indicate that Wnt16
is a downstream target gene of PR-Wnt4 signaling axis.
Interestingly, however, our data also show that ectopic
Wnt4-Wnt16 expression is not sufficient to induce side-
branching development, suggesting that other cooperat-
ing factors need to be provided. Taken together, we pro-
pose that PR signaling activates not only Wnt4-Wnt16
expression, but also other cooperating factors, and the
orchestrated crosstalk is required for lobuloalveolar devel-
opment during early pregnancy (Fig. 7).
Conclusion
In conclusion, we show that Wnt4 expression may be nec-
essary, but is not sufficient, to induce lobuloalveolar
development. We suggest that progesterone-induced col-
laborating factors may be required for Wnt4-mediated
mammary gland morphogenesis.
Methods
Plasmid constructions
TMILA plasmid was kindly provided by Dr. Lewis A. Cho-
dosh [15]. To generate the Wnt4 expression cassette, PCR
amplified mouse Wnt4 cDNA (a gift of Dr. Trevor C. Dale,
Scheme of potential pathway for induction of lobuloalveolar  development Figure 7
Scheme of potential pathway for induction of lobu-
loalveolar development. Accessory, progesterone-
induced factors (besides Wnt4) may be required to promote 
growth.
Wnt16 expression is induced by Wnt4 Figure 6
Wnt16 expression is induced by Wnt4. (A) Comparison 
of Wnt signaling-related gene expression profiles for virgin 
and pregnant (5.5 d.p) glands (upper panel) or for virgin and 
doxycycline-administered tet-Wnt4/MMTV-rtTA glands 
(lower panel). Vertical red lines indicate an arbitrary cut-off 
for significance (2 fold) up- or down-regulation, and the hori-
zontal blue line denotes a significance p value of 0.001. (B) 
Wnt16 expression is induced by canonical Wnt signaling ago-
nists in HC11 cells. HC11 cells were either transduced with 
Wnt signaling agonists encoding retroviruses, or were 
treated with conditioned media ± Wnt3a. Wnt16 mRNA 
amounts was measured using qPCR.BMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
Page 9 of 12
(page number not for citation purposes)
Cardiff University) was subcloned into the multiple clon-
ing site of TMILA plasmid. Mouse Wnt4 and Wnt1 expres-
sion vectors were generated by inserting the cDNA clone
downstream of an EF1α promoter sequences of a self-
inactivating lentiviral vector (SIN-EF1α; a gift of Dr. Rob-
ert G. Hawley, American Red Cross). Canonical Wnt sign-
aling reporter plasmids (superTOP-flash and superFOP-
flash) were kindly provided by Drs. Ajamete Kaykas and
Randall T. Moon (University of Washington). For in vitro
transcription of mouse Wnt4 and Wnt1, cDNAs were sub-
cloned into the multiple cloning site of the pCS2+ plasmid
that contains T7 and Sp6 promoter sequences.
Mice
All mice used in this study were maintained on an inbred
FVB/NJ background. They were housed and handled in
accordance with NIH guidelines, and administered by the
University of Wisconsin Animal Care and Use Committee.
FVB-Cdkn2a-/-(Ink4a/Arf null) mice were obtained from
MMHCC-NCI-Frederick. FVB-MMTV-rtTA mice (MTB
line) were kindly provided by Dr. Lewis C. Chodosh [16].
To generate doxycycline inducible Wnt4 transgenic mice,
the Wnt4 expression cassette (tet-Wnt4-IRES-luciferase)
was cut out from TMILA-Wnt4 plasmid using Not I restric-
tion enzyme, and the isolated fragment (~6.5 kb) was
injected to fertilized oocytes from FVB/NJ background.
Potential founders were identified by PCR-based genotyp-
ing using a luciferase gene-specific primer set (forward; 5'-
ATG GAA GAC GCC AAA AAC-3', reverse; 5-'CTG AAA
TCC CTG GTA ATC CG-3'). To generate tet-Wnt4/MMTV-
rtTA bitransgenic mice, male tet-Wnt4 mice were mated
with female MMTV-rtTA mice.
Doxycycline administration
To induce transgene expression, transgenic mice were
administered with 5% sucrose + 2 mg/ml doxycyline con-
taining water. Doxycycline-containing water was changed
every 2~3 days.
Whole Mounts
Inguinal mammary glands were fixed in Acetic acid/Etha-
nol (1:3) solution overnight at 4°C with mixing, and
stained in Carmine stain overnight. The stained glands
were dehydrated through a series of washes in 70, 95, and
100% ethanol for 30 min each. Fat was dissolved in
xylene. Pictures were taken by Axiovert 25 invert micro-
scope with AxioCam color digital camera (Zeiss) using
Open Lab software (Improvision).
Cell preparation
To generate immortalized mammary fibroblast cells,
endogenous epithelium-cleared mammary fat pads from
3 week old FVB-Cdkn2a-/-(Ink4a/Arf null) mice were
chopped with scissors to ~1 mm3  chucks and then
digested with collagenase (3 mg/ml; Worthington) and
trypsin (1.5 mg/ml; Worthington) for 90 min at 37°C
with agitation. Enzyme digested tissues were washed with
medium, and then filtered through a 40 μm cell strainer.
The filter-through fraction was mostly single cells and
these were plated on tissue culture plates. Only fibroblast
cells grew out in DMEM+10% FBS medium, deduced
from their expression of the fibroblast markers (Vimentin
and SMAα), and their lack of epithelia marker expression
(K8 and K5). Primary mammary epithelial cells were pre-
pared as previously described [39]
Luciferase assay
To measure luciferase reporter gene expression in doxy-
cyline-treated mammary glands, tissues were homoge-
nized in luciferase lysis buffer (Promega) using a glass
douncer and pestle on ice. Insoluble tissue lysates were
removed by centrifugation (12,000 g for 5 min), and their
protein concentration was determined by micro BCA pro-
tein assay kit (Pierce). Luciferase activity was measured
using 10 μg of protein lysate using Luciferase assay kit
(Promega) and a Monolight 3010 luminometer (Analyti-
cal Luminescence Laboratory).
For the canonical Wnt signaling reporter (superTOP-
flash) assay, 8 × 104 mammary epithelial cells or 5 × 104
mammary fibroblast cells were plated on 24-well plates,
and cells were transfected with Wnt4 or Wnt1 expression
vectors together with superTOP-flash reporter plasmid
(0.1 μg) and renilla luciferase gene (0.01 μg) using Lipo-
fectAmine 2000 (Gibco BRL). Approximate transfection
efficiencies were 10 and 30% for mammary epithelial cells
and mammary fibroblasts respectively. The total trans-
fected DNA amount was kept constant by adding either β-
galactosidase or eGFP expression plasmid. Cells were har-
vested in 200 μl of passive luciferase lysis buffer
(Promega) at 48 hrs after transfection, and both firefly
and renilla luciferase activities were measured with 10 μl
of cell lysate using Dual luciferase assay kit (Promega) as
instructed by manufacturer. To normalize transfection
efficiency, firefly luciferase activity was divided by the
renilla luciferase activity. Fold induction was determined
by dividing the luciferase unit results from samples trans-
fected with Wnt expressing plasmids by the results from
samples transfected with lacZ-containing control plas-
mids.
Southern blot analysis
Genomic DNAs (gDNAs) were isolated from tail biopsies,
and 10 μg of gDNA was cut with EcoR I restriction enzyme
for 10 hrs at 37°C. Digested gDNA was precipitated with
100% EtOH and resuspended with 9 μl of H2O to separate
through 0.8% agarose gel (TAE buffer, 25 V, overnight).
Gels were rinsed with water and incubated in 0.25 M HCl
solution for 30 min at room temperature (RT) with agita-
tion, and then neutralized with 0.4 M NaOH (20 min atBMC Developmental Biology 2009, 9:55 http://www.biomedcentral.com/1471-213X/9/55
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RT). DNAs were tranferred to Hybond N+  membrane
(Amersham Pharmacia Biotech) for 4 hrs using an alka-
line capillary downward blotting method (0.4 M NaOH
transfer buffer). Blotted membrane was hybridized with
TMILA-Wnt4 specific probes (labeled by random priming
of the TMILA-Wnt4 insert) using ULTRAhyb solutions
(Ambion) as instructed by the manufacturer.
Western blot analysis
Cells were lysed with lysis buffer (1% SDS + protease
inhibitor cocktail (Roche) in H2O) and protein concentra-
tions were determined by micro BCA protein assay kit.
Equal amounts of total protein were separated using 10%
SDS-PAGE, and electrotransferred to Immobilon P PVDF
membrane (Millipore). Membrane was blocked with 10%
non-fat milk + TBS-Tw (Tris buffered saline + 0.05%
Tween-20) followed by incubation with anti-mouse Wnt4
antibody (1:500, clone 55010, rat monoclonal, R&D sys-
tems) for 1 hr at RT. Membranes were then incubated with
HRP conjugated anti-rat IgG antibody (1:5000, Jackson
ImmunoResearch Lab) for 1 hr at RT, and visualized using
chemiluminescence reagent.
Zebrafish injection
Capped Wnt4 (or Wnt1) mRNA was transcribed from
pCS2+-Wnt4 (or Wnt1) plasmid using mMessage mMa-
chine transcription kit (Ambion) according to the manu-
facturer's instructions. mRNA was suspended in 0.1%
phenol red containing nuclease-free water and injected
into wild type zebrafish embryos at 1~4 cell stage. The
gain of function phenotype was assessed 24~26 hrs after
injection.
Real time quantitative PCR
Snap-frozen inguinal (lymph node removed) or thoracic
mammary glands were homogenized and total RNA was
isolated using ToTALLY RNA isolation kit (Ambion)
according to the manufacturer's instruction. 4 μg of total
RNA was reverse transcribed in 40 μl reaction volume
using StrataScript reverse transcriptase (Stratagene). 1 μl
of cDNA was mixed with 5 μl of Platinum Super Mix (Plat-
inum SYBER Green qPCR SuperMix-UDG with Rox, Invit-
rogen) and 4 μl of forward and reverse primer (0.5 μM),
and the PCR was performed using ABI7900-HT (50°C-2
min, 95°C-2 min, 45 cycles of 95°C-15 sec; 53°C-30 sec;
72°C-30 sec, and followed by a dissociation curve). The
oligonucleotide sequences of primers are as follows:
Wnt4-F; 5'-CGA GGA GTG CCA ATA CCA GT-3', Wnt4 R;
5'-GCC ACA CCT GCT GAA GAG AT-3', TBP-F; 5'-ACC
TTA TGC TCA GGG CTT G-3', TBP-R; 5'-TGG TGT TCT
GAA TAG GCT GTG-3', HPRT-F; 5'-CCT CAT GGA CTG
ATT ATG GAC AG-3', HPRT-R; 5'-AAT CCA GCA GGT
CAG CAA AG-3', K18-F; 5'-GAG GAG AGT ACC ACA GTT
GTC-3', K18-R; CCC GAG GCT GTT CTC CAA G-3'. All
data values were normalized by geomean of three differ-
ent internal control genes (HPRT, TBP, and K18) and rel-
ative gene expression data were determined using the 2-
ΔΔCt method [40]; ΔCt(sample) = Ct(sample) - Ct(geomean of internal
control genes), ΔΔCt(sample) = ΔCt(sample) - ΔCt(non-transgenic control
sample). The relative fold induction was calculated by divid-
ing each value by average value of non-transgenic control
samples (7 week old gland).
Superarray analysis
Total RNA isolation was performed using the RNeasy
Lipid Tissue Mini Kit (Qiagen). Mammary gland tissue,
weighing approximately 100 mg, was cut into smaller
pieces and placed into 2 × 2 ml centrifuge tubes contain-
ing 1 ml of QIAzol Lysis Reagent. The tissues were homog-
enized (Polytron PT 2100), and RNA isolation was
completed as per manufacturer's instructions.
Gene expression was quantified using the RT2 ProfilerTM
PCR Array System (SABiosciences). 3.0 ug of total RNA (in
40 μl) from mammary gland was used for reverse tran-
scription using the RT2 First Strand Kit. Reactions were
diluted to 13.5 ng/ul, RT2 Real-Time SYBER Green/ROX
PCR Master Mix was mixed according to the manufac-
ture's instructions. 10 μl reactions were loaded into each
well of a 384 well plate, SABiosciences #APMM-043E-4
with 3 gene substitutions (Axin2, FZD9, FZD10), contain-
ing various primer pairs in quadruplicates. 4 samples were
run on one plate, and then repeated to produce duplicate
results. We used a two-step cycling program that was rec-
ommended by the manufacturer for use with the ABI
7900 HT. The Baseline and Threshold values were manu-
ally adjusted for each plate to the same settings (2-12
cycles for the Baseline, and 0.1 Threshold). Quality con-
trol for the data included: well volumes, dissociation
curves, and fluorescence graphs were examined for prob-
lem wells; the array plates also contained controls for
genomic contamination, reverse transcription, and PCR.
Results were analyzed with Microsoft Excel spreadsheet
templates found at http://www.sabiosciences.com/
support_manual.php.
Abbreviations
Lrp5: Lipoprotein receptor related protein-5; PR: Proges-
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